EORTC-NCI-AACR Molecular Targets and Cancer Therapeutics Symposium - X4 Pharmaceuticals

EORTC-NCI-AACR Molecular Targets and Cancer Therapeutics Symposium

EORTC-NCI-AACR Molecular Targets and Cancer Therapeutics Symposium

November 2016

Anti-tumor activity of X4P-001 in RCC with VEGF inhibitor

© 2023 X4 Pharmaceuticals, Inc. All rights reserved. Terms of Use | Privacy Policy